![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 12, 7438-7444, March 21, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
1


¶



**
2
From the
Departments of
Pathology, 
Cell Biology, and **Pharmacology/Toxicology, the
Comprehensive Cancer Center, and the ¶Epitope Recognition and Immunoreagent Core Facility, University of Alabama, Birmingham, Alabama 35294 and the ||Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama 36688
The BRMS1 metastasis suppressor interacts with the protein AT-rich interactive domain 4A (ARID4A, RBBP1) as part of SIN3·histone deacetylase chromatin remodeling complexes. These transcriptional co-repressors regulate diverse cell phenotypes depending upon complex composition. To define BRMS1 complexes and their roles in metastasis suppression, we generated BRMS1 mutants (BRMS1mut) and mapped ARID4A interactions. BRMS1L174D disrupted direct interaction with ARID4A in yeast two-hybrid genetic screens but retained an indirect association with ARID4A in MDA-MB-231 and -435 human breast cancer cell lines by co-immunoprecipitation. Deletion of the first coiled-coil domain (BRMS1
CC1) did not disrupt direct interaction in yeast two-hybrid screens but did prevent association by co-immunoprecipitation. These results suggest altered complex composition with BRMS1mut. Although basal transcription repression was impaired and the pro-metastatic protein osteopontin was differentially down-regulated by BRMS1L174D and BRMS1
CC1, both down-regulated the epidermal growth factor receptor and suppressed metastasis in MDA-MB-231 and -435 breast cancer xenograft models. We conclude that BRMS1mut, which modifies the composition of a SIN3·histone deacetylase chromatin remodeling complex, leads to altered gene expression profiles. Because metastasis requires the coordinate expression of multiple genes, down-regulation of at least one important gene, such as the epidermal growth factor receptor, had the ability to suppress metastasis. Understanding which interactions are necessary for particular biochemical/cellular functions may prove important for future strategies targeting metastasis.
Received for publication, November 19, 2007 , and in revised form, January 9, 2008.
1 Both authors contributed equally to this work.
2 To whom correspondence should be addressed: Dept. of Pathology, 1670 University Blvd., Rm. VH-G019, Birmingham, AL 35294-0019. Tel.: 205-934-2961; Fax: 205-975-1126; E-mail: DanWelch{at}uab.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |